Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T21:20:48.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:32:39.000Z thumbnail image
  7. Check
    26 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of versions of the study record for the clinical trial on Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab in adults with unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC). This change reflects the addition of a new version of the study record, which may include updated information or results.
    Difference
    0.3%
    Check dated 2024-05-22T21:34:27.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:47:27.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.